Ja. Brandenburg et al., Clinical presentation, processes and outcomes of care for patients with pneumococcal pneumonia, J GEN INT M, 15(9), 2000, pp. 638-646
OBJECTIVE: To describe the presentation, resolution of symptoms, processes
of care, and outcomes of pneumococcal pneumonia, and to compare features of
the bacteremic and nonbacteremic forms of this illness.
DESIGN:A prospective cohort study,
SETTING: Five medical institutions in 3 geographic locations.
PARTICIPANTS: Inpatients and outpatients with community-acquired pneumonia
(CAP),
MEASUREMENTS: Sociodemographic characteristics, respiratory and nonrespirat
ory symptoms, and physical examination findings were obtained from intervie
ws or chart review. Severity of illness was assessed using a validated pred
iction rule for short-term mortality in CAP, Pneumococcal pneumonia was cat
egorized as bacteremic; nonbacteremic, pure etiology; or nonbacteremic, mix
ed etiology,
MAIN RESULTS: One hundred fifty-eight (6.9%) of 2,287 patients (944 outpati
ents, 1,343 inpatients) with CAP had pneumococcal pneumonia. Sixty-five (41
%) of the 158 with pneumococcal pneumonia were bacteremic: 74 (47%) were no
nbacteremic with S, pneumoniae as sole pathogen: and 19 (12%) were nonbacte
remic with S. pneumoniae as one of multiple pathogens. The pneumococcal bac
teremia sate for outpatients was 2.6% and for inpatients it was 6.6%. Cough
, dyspnea, and pleuritic pain were common respiratory symptoms. Hemopytsis
occurred in 16% to 22% of the patients. A large number of nonrespiratory sy
mptoms were noted. Bacteremic patients were less likely than nonbacteremic
patients to have sputum production and myalgias (60% vs 82% and 33% vs 57%,
respectively; P < .01 for both), more likely to have elevated blood urea n
itrogen and serum creatinine levels, and more Likely to receive pencillin t
herapy. Half of bacteremic patients were in the low risk category for short
-term mortality (groups I to III), similar to the nonbacteremic patients. N
one of the 32 bacteremic patients in risk groups I to III died, while 7 of
23 (30%) in risk group V died, Intensive care unit admissions and pneumonia
-related mortality were similar between bacteremic and nonbacteremic groups
. although 46% of the bacteremic group had respiratory failure compared wit
h 32% and 37% for the other groups. The nonbacteremic pure etiology patient
s returned to household activities faster than bacteremic patients. Symptom
s frequently persisted at 30 days: cough (50%); dyspnea (53%): sputum produ
ction (48%); pleuritic pain (13%); and fatigue (63%).
CONCLUSIONS: There were few differences in the presentation of bacteremic a
nd nonbacteremic pneumococcal pneumonia, About half of bacteremic pneumococ
cal pneumonia patients were at low risk for mortality. Symptom resolution f
requently was slow.